M. Lamba

A randomized phase 2a efficacy and safety trial of the topical <scp>J</scp> anus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis

W.C. Ports, Sairah Khan, Shu-Ping Lan et al. · British Journal of Dermatology · 2013 · 202 citations · Full text

Medicine, Dermatology, Pharmacology +13

Phase I study of CC-90010, a reversible, oral BET inhibitor in patients with advanced solid tumors and relapsed/refractory non-Hodgkin's lymphoma

Víctor Moreno, María Vieito, Tatiana Hernández‐Guerrero et al. · Annals of Oncology · 2020 · 68 citations · Full text

Medicine, Oncology, Pharmacology +13

Evaluation of the Effect of Tofacitinib Exposure on Outcomes in Kidney Transplant Patients

Flavio Vincenti, Stéphan Busque, Philip J. O’Connell et al. · American Journal of Transplantation · 2015 · 54 citations

Medicine, Nephrology, Pharmacology +14

Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib

M. Lamba, MM Hutmacher, D.E. Furst et al. · Clinical Pharmacology & Therapeutics · 2016 · 38 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

Exploring perspectives of stigma and discrimination among people with lived experience of mental health conditions: a co-produced qualitative study

Petra C. Gronholm, Sarah Kline, M. Lamba et al. · EClinicalMedicine · 2024 · 21 citations · Full text

Social Sciences, Psychiatry, Psychology +11